DNLI icon

Denali Therapeutics

216 hedge funds and large institutions have $3.68B invested in Denali Therapeutics in 2024 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 58 reducing their positions, and 22 closing their positions.

Holders
216
Holders Change
+13
Holders Change %
+6.4%
% of All Funds
3.13%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
36
Increased
79
Reduced
58
Closed
22
Calls
$2.01M
Puts
$1.17M
Net Calls
+$840K
Net Calls Change
-$1.46M
Name Holding Trade Value Shares
Change
Shares
Change %
D.E. Shaw & Co
226
D.E. Shaw & Co
New York
-$690K -29,721 Closed
HLA
227
Hamilton Lane Advisors
Pennsylvania
-$596K -25,657 Closed
FRM
228
Fox Run Management
Connecticut
-$566K -24,390 Closed
EGM
229
Engineers Gate Manager
New York
-$258K -11,130 Closed
PCM
230
Prelude Capital Management
New York
-$240K -10,343 Closed
QL
231
Quarry LP
New York
-$151K -6,500 Closed
Pacer Advisors
232
Pacer Advisors
Pennsylvania
-$20K -862 Closed
AF
233
Allworth Financial
California
-$1.37K -64 Closed
VNA
234
Valley National Advisers
Pennsylvania
-$1K -50 Closed
IC
235
Innealta Capital
Texas
-$696 -30 Closed
CIBC Private Wealth Group
236
CIBC Private Wealth Group
Georgia
-$21 -1 Closed